Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 7 Issue 1

Results of Testing for Viral Hepatitis B and C in the Kyrgyz Republic, 2008 -2021

Tobokalova Saparbu T*, Aitieva Jyldyz T, Zairova Gulzada M and Saydykova Altynai A

Kyrgyz State Medical Institution of Retraining and Advanced Training Named After S.B Daniyarov, Bishkek, Professorial Course of Infectious Diseases, Kyrgyzstan

*Corresponding Author: Tobokalova Saparbu T, Kyrgyz State Medical Institution of Retraining and Advanced Training Named After S.B Daniyarov, Bishkek, Professorial Course of Infectious Diseases, Kyrgyzstan.

Received: November 01, 2022; Published: December 21, 2022

Abstract

Introduction: Testing and early detection of hepatitis B and C infection determine indications for the services of prevention and treatment and are a key component for effective response to the epidemic of these infections.

The Aim of the Study: Analysis of the state early detection of viral hepatitis B and C in Kyrgyzstan to develop a mass testing program as a stage towards eliminating the epidemic of blood-borne viral hepatitis in the country.

Materials and Methods: State Reporting Forms No. 1 “Report on infectious and parasitic disease” for 2008–2021 were reviewed. The data was processed by Epi Info 3.8.1

Results” The Kyrgyz Republic belongs to countries with high incidence of viral hepatitis B and C. The incidence of acute and chronic viralhepatitis B in 2021 amounted to 29.2 per 100,000 population, and hepatitis C -10.8. Based on the results of testing by some healthcare organizations, the hepatitis B virus infection of the population ofvaries from 4.6% to 7.3% and hepatitis C - from 3.1% to 7.7%. Data of official statistics (Department of Disease Prevention and State Sanitary-Epidemiologic Surveillance and the Centre of Electronic Healthcare) on theprevalence of acute and chronic hepatitis B and C differ considerably. Thereis no information about the exact number of patients with all forms of hepatitisВ and C, cirrhosis and liver cancer in their outcome.

Conclusions: To ensure the access of patients with chronic viral hepatitis and cirrhosis in their outcome to the services of diagnostics, highly effective methods of treatment and preventionit is needed to conduct a phased mass testing of the adult population for viral hepatitis B and C in order to determine the true number of such patients.

Keywords: Blood-Borne Viral Hepatitis, Viral Hepatitis B, Viral Hepatitis C, Diagnosis, Mass Testing, Prevention

References

  1. Patel EU., et al. “Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011‐2016”. Clinical Infectious Diseases 69 (2019): 709‐712.
  2. Guidelines for testing for Hepatitis B and C, Geneva, WHO (2017).
  3. Do A and Reo NS. “Chronic viral hepatitis: current management and future directions”. Hepatology Communications 4 (2020): 329-341.
  4. Tobokalova ST. “Acute hepatitis B and D in children with concomitant pathology”. DISS Dr. Medical Sciences (2004).
  5. “Report on the movement of infectious and parasitic diseases”. state reporting form No. 1 of the Department for Disease Prevention and State Sanitary and Epidemiological Surveillance under the Ministry of Health of the Kyrgyz Republic (2021).
  6. Principles of Epidemiology in Public Health Practice. Atlanta, GA 30333 (1998).
  7. WHO, UNODC and UNAIDS technical guidance for countries on the development of goals within the framework of the concept of ensuring universal access to HIV prevention, treatment and care among IDUs. Geneva:WHO (2012).
  8. Nogoibaeva KA and Tobokalova ST. “Etiological and Epidemiological Characteristics of Lethality from Acute Viral Hepatitis, Kyrgyzstan, 2009-2018”. Journal of Microbiology, Epidemiology and Immunobiology, Russian Journal 97.1 (2020): 40- doi: 10.36233/0372-9311-2020-97-1-40.
  9. Zairova GM., et al. “Epidemiological features of familial foci of hepatitis B, C and D”. VESTNIK of KSMA named after I.K. AKHUNBAEV 4 (2015): 135-
  10. Nurmatov ZSh. “Evaluation of the effectiveness of vaccination of newborns against hepatitis B in Bishkek and Jalalabat, Kyrgyzstan, 2005”. Medicine of Kyrgyzstan 3 (2007): 175-
  11. Patton H and Tran TT. “Management of hepatitis В during pregnancy”. Nature Reviews Gastroenterology and Hepatology 11.7 (2020): 402-40
  12. Eckman MH., et al. “The cost- effectiveness of screening for chronic hepatitis B infection in the United States”. Clinical Infectious Diseases 11 (2011): 1294-1306.

Citation

Citation: Tobokalova Saparbu T., et al. “Results of Testing for Viral Hepatitis B and C in the Kyrgyz Republic, 2008 -2021”.Acta Scientific Medical Sciences 7.1 (2023): 74-79.

Copyright

Copyright: © 2022 Tobokalova Saparbu T., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is February 15, 2023.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US